Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 SEK | 0.00% | +0.50% | -32.21% |
04-30 | Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-14 | Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 36M 3.37M 4.59M | Sales 2025 * | 60M 5.62M 7.65M | Capitalization | 217M 20.34M 27.67M |
---|---|---|---|---|---|
Net income 2024 * | -11M -1.03M -1.4M | Net income 2025 * | 20M 1.87M 2.55M | EV / Sales 2024 * | 5.58 x |
Net cash position 2024 * | 16M 1.5M 2.04M | Net cash position 2025 * | 30M 2.81M 3.82M | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
-20.2
x | P/E ratio 2025 * |
11.1
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.17% |
1 week | +0.50% | ||
Current month | -4.27% | ||
1 month | -12.55% | ||
3 months | -28.87% | ||
6 months | -22.31% | ||
Current year | -32.21% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 07-12-31 | |
Gunnar Tufveson
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Fredrik Carlsson
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Magnus Nilsson
BRD | Director/Board Member | 68 | 20-11-17 |
Director/Board Member | - | 04-12-31 | |
Chairman | 51 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 10.1 | 0.00% | 6 681 |
24-05-14 | 10.1 | +3.06% | 6,633 |
24-05-13 | 9.8 | -2.97% | 3,932 |
24-05-10 | 10.1 | +0.50% | 9,275 |
24-05-08 | 10.05 | 0.00% | 898 |
Delayed Quote Nasdaq Stockholm, May 15, 2024 at 07:36 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.21% | 20.06M | |
+15.09% | 74.45B | |
+11.35% | 9.18B | |
+54.35% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-20.85% | 2.41B | |
+16.88% | 2.39B | |
-29.25% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- CLBIO Stock